openPR Logo
Press release

Burns Pipeline Therapeutics Assessment Report 2024 (Updated)

12-02-2024 09:37 AM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Burns Pipeline

Burns Pipeline

DelveInsight's, "Burns Pipeline Insight 2024" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Burns pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Explore our latest breakthroughs in Burns Research. Learn more about our innovative pipeline today! @ Burns Pipeline Outlook- https://www.delveinsight.com/sample-request/burns-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Burns Pipeline Report
• In November 2024:- Molnlycke Health Care AB- The primary objective of this study is to evaluate the clinical safety and performance of all study dressings, separately, when used as intended in moderate to high exuding partial thickness burns (PTBs) through assessment of wound progression from baseline to the Subject's last clinical follow-up visit. The dressings are intended to promote healing through the management of the wound environment.
• In November 2024:- SpectralMD- The purpose of this study is to validate the algorithm for burn healing assessment by the Spectral MD DeepView device which would provide burn healing potential assessment.
• DelveInsight's Burns pipeline report depicts a robust space with 12+ active players working to develop 12+ pipeline therapies for Burns treatment.
• The leading Burns Companies such as NeoMatrix Therapeutics, Amniotics, Alloksys Life Sciences, Medline Industries, Skingenix, Inc., Anterogen, Noveome Biotherapeutics, Phagelux Inc., Bioharmony Therapeutics, Amarantus Bioscience, and others.
• Promising Burns Therapies such as PluroGel, SN514-066b, Pathogen-Reduced Plasma, PMS-101 and others.

Stay informed about the cutting-edge advancements in Burns treatments. Download for updates and be a part of the revolution in care @ Burns Clinical Trials Assessment- https://www.delveinsight.com/sample-request/burns-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Burns Emerging Drugs

• NMT- cP12: NeoMatrix Therapeutics
NMT- cP12 is a novel, bioactive peptide for intravenous treatment of burns within 2 to 4 hours of injury. NMT- cP12 has the potential to limit burn injury progression, shorten healing time, and reduce scarring of deep or extensive burns in hospitalized patients. FDA has granted NMT-cP12 Orphan and Fast Track Designation for severe burns. NMT-cP12 is a novel Fibronectin (FN) derived, 14-mer peptide (P12) from the first FN type III repeat that promotes mesenchymal cell growth, proliferation and migration in vitro and acts synergistically with a variety of growth factors including platelet-derived growth factor-BB. FN has been shown to play a vital role in wound healing and is deficient in burn patients' wounds and blood. P12 protects adult human dermal fibroblasts from cell death induced by oxidative and cytokine stress in vitro. In addition, blood vessel occlusion in burns is well-known and results in impaired oxygenation and ultimately tissue necrosis in the peri-burn tissue. NMT-cP12 has been demonstrated in animal models to vasodilate the microvasculature and to reduce blood vessel occlusion. Thereby, a single infusion of NMT-cP12 limits burn injury progression, speeds healing and reduces scarring in a porcine burn model.

Learn more about Burns Drugs opportunities in our groundbreaking Burns Research and development projects @ Burns Unmet Needs- https://www.delveinsight.com/sample-request/burns-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Burns Companies
NeoMatrix Therapeutics, Amniotics, Alloksys Life Sciences, Medline Industries, Skingenix, Inc., Anterogen, Noveome Biotherapeutics, Phagelux Inc., Bioharmony Therapeutics, Amarantus Bioscience, and others.

Burns pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical.
• Molecule Type

Burns Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
• Product Type

Discover the latest advancements in Burns treatment by visiting our website. Stay informed about how we're transforming the future of disease @ Burns Market Drivers and Barriers, and Future Perspectives- https://www.delveinsight.com/sample-request/burns-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Burns Pipeline Report
• Coverage- Global
• Burns Companies- NeoMatrix Therapeutics, Amniotics, Alloksys Life Sciences, Medline Industries, Skingenix, Inc., Anterogen, Noveome Biotherapeutics, Phagelux Inc., Bioharmony Therapeutics, Amarantus Bioscience, and others.
• Burns Therapies- PluroGel, SN514-066b, Pathogen-Reduced Plasma, PMS-101 and others.
• Burns Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Burns Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

For a detailed overview of our latest research findings and future plans, read the full details of Burns Pipeline on our website @ Burns Emerging Drugs and Companies- https://www.delveinsight.com/sample-request/burns-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Introduction
2. Executive Summary
3. Burns: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Burns - DelveInsight's Analytical Perspective
7. Late Stage Products (Phase III)
8. Drug name: Company name
9. Drug profiles in the detailed report…..
10. Mid Stage Products (Phase II)
11. bRESCAP: Alloksys Life Sciences
12. Drug profiles in the detailed report…..
13. Early Stage Products (Phase I)
14. NMT- cP12: NeoMatrix Therapeutics
15. Drug profiles in the detailed report…..
16. Preclinical and Discovery Stage Products
17. BH02: Bioharmony Therapeutics
18. Drug profiles in the detailed report…..
19. Inactive Products
20. Burns Key Companies
21. Burns Key Products
22. Burns- Unmet Needs
23. Burns- Market Drivers and Barriers
24. Burns- Future Perspectives and Conclusion
25. Burns Analyst Views
26. Burns Key Companies
27. Appendix

List of Highly Demanded Research Reports in 2024

cxcr inhibitors market: https://www.delveinsight.com/report-store/selective-inhibitor-of-the-cxcr4-chemokine-receptor-market-forecast
fertility monitoring devices market: https://www.delveinsight.com/report-store/fertility-monitoring-devices-fertility-testing-devices-market
ornithine transcarbamylase deficiency market: https://www.delveinsight.com/report-store/ornithine-transcarbamylase-deficiency-otc-deficiency-market
orthopedic power devices market: https://www.delveinsight.com/report-store/orthopedic-power-devices-market
otitis media market: https://www.delveinsight.com/report-store/otitis-media-market
persistent depressive disorder market: https://www.delveinsight.com/report-store/major-depressive-disorder-market
smoking cessation market: https://www.delveinsight.com/report-store/smoking-cessation-market
surgical sealant market: https://www.delveinsight.com/report-store/surgical-sealant-and-adhesives-market
urothelial carcinoma market: https://www.delveinsight.com/report-store/urothelial-carcinoma-market
vascular grafts market: https://www.delveinsight.com/report-store/vascular-grafts-market
vital sign monitors devices market: https://www.delveinsight.com/report-store/vital-sign-monitors-external-remote-patient-monitoring-devices-market
aplastic anemia market: https://www.delveinsight.com/report-store/aplastic-anemia-market
cart pipeline: https://www.delveinsight.com/report-store/car-t-pipeline-insight
celiac disease market: https://www.delveinsight.com/report-store/celiac-disease-cd-market
coronary stents market: https://www.delveinsight.com/report-store/coronary-stents-market-market
diabetic gastroparesis market: https://www.delveinsight.com/report-store/diabetic-gastroparesis-market-size
elastomeric pump market: https://www.delveinsight.com/report-store/elastomeric-pump-market
friedreich's ataxia market: https://www.delveinsight.com/report-store/friedreichs-ataxia-market
hay fever conjunctivitis market: https://www.delveinsight.com/report-store/hay-fever-conjunctivitis-market
hip replacement devices market: https://www.delveinsight.com/report-store/hip-reconstruction-devices-market
joint reconstruction devices market: https://www.delveinsight.com/report-store/joint-reconstruction-devices-market
periodontal disease market: https://www.delveinsight.com/report-store/periodontal-disease-market
psoriasis vulgaris market: https://www.delveinsight.com/report-store/psoriasis-vulgaris-market
ranibizumab biosimilars market: https://www.delveinsight.com/report-store/ranibizumab-biosimilars-insight
short bowel syndrome drug market: https://www.delveinsight.com/report-store/short-bowel-syndrome-market
short bowel syndrome market: https://www.delveinsight.com/report-store/short-bowel-syndrome-market
thrombectomy devices market: https://www.delveinsight.com/report-store/thrombectomy-devices-market
type 1 diabetes market: https://www.delveinsight.com/report-store/type-1-diabetes-market
adhd market: https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
attention deficit hyperactivity disorder market: https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
avascular necrosis market: https://www.delveinsight.com/report-store/avascular-necrosis-market
biopsy devices market: https://www.delveinsight.com/report-store/biopsy-devices-market
embolotherapy market: https://www.delveinsight.com/report-store/embolotherapy-market
hydrocephalus treatment market: https://www.delveinsight.com/report-store/hydrocephalus-treatment-market
liquid biospy for cancer diagnostics market: https://www.delveinsight.com/report-store/liquid-biopsy-in-cancer-diagnostics-market
skin grafting devices market: https://www.delveinsight.com/report-store/skin-grafting-devices-market
testicular neoplasm market: https://www.delveinsight.com/report-store/testicular-neoplasm-market
uk healthcare report: https://www.delveinsight.com/report-store/uk-healthcare-outlook-report
vascular access devices market: https://www.delveinsight.com/report-store/vascular-access-device-market
brucellosis market: https://www.delveinsight.com/report-store/brucellosis-market
catheter stabilization devices market: https://www.delveinsight.com/report-store/catheter-stabilization-securement-device-market
dyspepsia market: https://www.delveinsight.com/report-store/functional-dyspepsia-market-share
heart pump devices market: https://www.delveinsight.com/report-store/heart-pump-device-market
phototherapies for psoriasis market: https://www.delveinsight.com/report-store/phototherapies-for-psoriasis-market
radial artery compression device market: https://www.delveinsight.com/report-store/radial-artery-compression-devices-market
sarcopenia market: https://www.delveinsight.com/report-store/sarcopenia-market
shingles market: https://www.delveinsight.com/report-store/shingles-market
surgical site infections market: https://www.delveinsight.com/report-store/surgical-site-infections-ssi-market
venous ulcer market: https://www.delveinsight.com/report-store/venous-leg-ulcer-market
viscosupplementation devices market: https://www.delveinsight.com/report-store/viscosupplementation-devices-market
artificial disc market: https://www.delveinsight.com/report-store/artificial-disc-market
healthcare consulting solutions: https://www.delveinsight.com/consulting
meningococcal meningitis market: https://www.delveinsight.com/report-store/meningococcal-meningitis-market
moderate to severe plaque psoriasis market: https://www.delveinsight.com/blog/us-psoriasis-treatment
pertussis market: https://www.delveinsight.com/report-store/pertussis-market
spinal trauma devices market: https://www.delveinsight.com/report-store/spinal-trauma-devices-market-market
surgical energy instruments market: https://www.delveinsight.com/report-store/surgical-energy-instruments-electrosurgical-devices-market
temporomandibular disorders market: https://www.delveinsight.com/report-store/temporomandibular-disorders-market
transcatheter heart valve replacement devices market: https://www.delveinsight.com/report-store/transcatheter-aortic-valve-replacement-market
urinary catheters market: https://www.delveinsight.com/report-store/urinary-catheters-market
attention deficit hyperactivity disorder adhd market: https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
coronary angioplasty market: https://www.delveinsight.com/report-store/coronary-stents-market-market
nonalcoholic steatohepatitis market: https://www.delveinsight.com/report-store/nonalcoholic-steatohepatitis-nash-market
orthopedic splints device market: https://www.delveinsight.com/report-store/orthopedic-splints-market
perennial allergic rhinitis market: https://www.delveinsight.com/report-store/perennial-allergic-rhinitis-market
pipeline assessment services: https://www.delveinsight.com/consulting/pipeline-assessment-services
schistosomiasis market: https://www.delveinsight.com/report-store/schistosomiasis-market
venous thromboembolism market: https://www.delveinsight.com/report-store/venous-thromboembolism-market
bacterial meningitis market: https://www.delveinsight.com/report-store/meningococcal-meningitis-market
nk cell therapy market: https://www.delveinsight.com/report-store/nk-cell-therapy-market
overactive bladder syndrome market: https://www.delveinsight.com/report-store/overactive-bladder-market
peripheral nerve injuries market: https://www.delveinsight.com/report-store/peripheral-nerve-injuries-market
tendonitis market: https://www.delveinsight.com/report-store/tendonitis-market
endoscopic ultrasound market: https://www.delveinsight.com/report-store/endoscopic-ultrasound-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Burns Pipeline Therapeutics Assessment Report 2024 (Updated) here

News-ID: 3765902 • Views:

More Releases from DelveInsight Business Research LLP

Metastatic Colorectal Cancer Pipeline Gains Momentum: 150+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
Metastatic Colorectal Cancer Pipeline Gains Momentum: 150+ Companies Lead the Ch …
DelveInsight's, "Metastatic Colorectal Cancer Pipeline Insight 2026" report provides comprehensive insights about 150+ companies and 180+ pipeline drugs in Metastatic Colorectal Cancer pipeline landscape. It covers the Metastatic Colorectal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Metastatic Colorectal Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive Metastatic Colorectal Cancer pipeline products in this
Lupus Nephritis Pipeline Accelerates as 35+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
Lupus Nephritis Pipeline Accelerates as 35+ Pharma Companies Rigorously Develop …
DelveInsight's "Lupus Nephritis Pipeline Insight 2026" report provides comprehensive insights about 35+ companies and 42+ pipeline drugs in the Lupus Nephritis pipeline landscape. It covers the Lupus Nephritis Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Lupus Nephritis Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Curious about the latest updates
Sickle Cell Disease Clinical Trial Pipeline Analysis: 55+ Key Companies Shaping the Future of Sickle Cell Disease Therapeutics | DelveInsight
Sickle Cell Disease Clinical Trial Pipeline Analysis: 55+ Key Companies Shaping …
DelveInsight's Sickle Cell Disease Pipeline Insight 2026 report provides comprehensive global coverage of available, marketed, and pipeline Sickle Cell Disease therapies in various stages of clinical development. The report provides insights into 55+ companies and 60+ drugs in the Sickle Cell Disease competitive landscape, covering therapeutic assessments by product type, stage, route of administration, and molecule type, as well as inactive pipeline products. Key takeaways from the Sickle Cell Disease Clinical
Sjogren's Syndrome Clinical Trial Pipeline Analysis: 20+ Key Companies Shaping the Future of Sjogren's Syndrome Therapeutics | DelveInsight
Sjogren's Syndrome Clinical Trial Pipeline Analysis: 20+ Key Companies Shaping t …
DelveInsight's Sjogren's Syndrome Pipeline Insight 2026 report provides comprehensive global coverage of available, marketed, and pipeline Sjogren's Syndrome therapies in various stages of clinical development. The report provides insights into 20+ companies and 22+ pipeline drugs in the Sjogren's Syndrome pipeline landscape, covering clinical and nonclinical stage products, therapeutic assessments, and inactive pipeline products. Key takeaways from the Sjogren's Syndrome Clinical Trial Landscape Report • DelveInsight's Sjogren's Syndrome pipeline report depicts a robust

All 5 Releases


More Releases for Burns

Pepe (PEPE) Targets $500 Million in Token Burns While Ruvi (RUVI) Burns Supply F …
A community-driven burn roadmap this week set a target of $500 million in cumulative Pepe (PEPE) token burns by mid-2026, a milestone that at the current spot price of $0.00000282 would remove roughly 177 trillion tokens, about 42% of circulating supply, per CoinGabbar. The burns rest on community goodwill rather than income. That contrast is drawing attention to the Ruvi (RUVI) decentralized AI superapp (ruvi.io https://ruvi.io), where supply reduction is
Injective Burns 7 Million INJ in an On-Chain Buyback as Ruvi (RUVI) Ties Supply …
Injective recently completed an on-chain Community BuyBack that burned 7 million INJ and returned roughly $776,000 of protocol revenue to participants, a live demonstration of a buyback-and-burn revenue model running at the protocol level. As that result circulated across crypto media this week, some investors are also weighing the Ruvi (RUVI) decentralized AI superapp (ruvi.io https://ruvi.io), an audited platform already running 20+ live AI models that pays contributors in $RUVI
Best Crypto Presale Growth: IONX Chain Token Burns
In the fast-evolving world of cryptocurrency, finding projects with real potential can feel overwhelming, especially for beginners. That's where IONX Chain stands out as a promising option in the realm of best crypto presale growth. This AI-powered Layer 1 blockchain is designed to tackle some of the biggest challenges in the space, like slow transaction speeds and high fees, while incorporating innovative features such as token burns to enhance long-term
Burns Market Massive Growth opportunity Ahead
Introduction Burn injuries remain one of the most severe forms of trauma, affecting millions of people worldwide every year. They can result from heat, chemicals, radiation, or electricity and often require long-term clinical care, reconstructive surgeries, and rehabilitation. Beyond immediate medical intervention, burn injuries create lasting impacts on quality of life, healthcare systems, and economic resources. The global burns market is evolving rapidly with advancements in wound care technologies, skin grafting procedures,
Burns Funding Names Rogul Director of Business Development
Burns Funding (www.burnsfunding.com), a venture debt lender that helps entrepreneurs and investors obtain funding for their businesses, has named Daniel "The Dan" Rogul as Director of Business Development. Daniel Rogul, whose past associates credited him with the name of "The Dan" both because of his innate ability to recognize partnership opportunities and close deals, as well as the high standards he has in how he treats people, joins Grace Gillespie, which
Steve & Burns: Simplifying Tax Consulting for Small Businesses
Dallas, Texas - Steve & Burns Tax Consulting Services, a leading tax advisory firm, is proud to announce its comprehensive range of tax consulting services [https://steveandburns.com/] specifically tailored to meet the needs of small businesses. As businesses continue to navigate complex tax laws, Steve & Burns offers expert guidance to help companies minimize tax liabilities, optimize tax strategies, and ensure compliance with the latest regulations. Specialized Tax Consulting Services for Small